Proteins are integral players in all biological processes, including enzymatic catalysis, metabolism, energy conversion, cell signaling, cellular communication, cellular structural support, cell growth and death, and more. They perform their different functions through specific three-dimensional arrangements of amino acids. Understanding the structure of a protein is an important factor in understanding its function, especially for predicting the mode of action of a drug and its function and regulation. BOC Sciences' hydrogen/deuterium exchange-based mass spectrometry (HDX MS) is an analytical tool for characterizing protein structure and conformational transitions with extraordinary speed and sensitivity.
We excel at combining data from HDX MS with other structural information from X-ray crystallography, NMR, cryo-EM, small angle X-ray scattering (SAXS), and molecular dynamics simulations to derive the most informed insights into protein structure. In conclusion. Our services include:
Fig.1 Application of HDX MS to the study of viruses and virus-related proteins.[1]
Characterization of proteins is a very important part of biopharmaceutical development. This happens at many stages (eg, research, development, processing, formulation, etc.). Our characterization studies are primarily based on the size, complexity of the protein, and the need to analyze higher-order structures.
Monoclonal antibodies are the majority of biopharmaceutical proteins currently used to treat diseases. Their structural characterization has been challenging due to their large size and complexity (e.g., disulfide bonds, glycosylation, etc.). Our HDX MS technology plays an important role in studying the conformation and dynamics of such complex molecules, such as understanding the impact of post-translational modifications on antibody structure.
In addition to antibodies, there are other biopharmaceuticals featuring HDX. Our research objects include protein hormones, coagulation factors, proteases, etc.
BOC Sciences' HDX MS technology is a cutting-edge technique for characterizing protein structures. Our technique has many advantages in measuring conformational changes using a small number of samples, with high sensitivity and speed, greatly expanding its range of applications.
If you are interested in our services, please contact us immediately, then fill in the complete inquiry form, and we will reply to you as soon as possible.
References
BOC Sciences' DCL™ platform provides a deuterium strategy for both high-end custom markets and basic product needs. Our main business areas cover drug development, omics analysis, scientific research testing, and other markets, and strive to promote the development of biomedicine and scientific research.